Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG.

Pharmacol Rev. 2002 Jun;54(2):161-202. Review.

2.

Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs.

Stengel PW, Rippy MK, Cockerham SL, Devane WA, Silbaugh SA.

Eur J Pharmacol. 1998 Aug 14;355(1):57-66.

PMID:
9754939
3.

The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine.

Arreaza G, Devane WA, Omeir RL, Sajnani G, Kunz J, Cravatt BF, Deutsch DG.

Neurosci Lett. 1997 Sep 26;234(1):59-62.

PMID:
9347946
4.

Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide.

Collin C, Devane WA, Dahl D, Lee CJ, Axelrod J, Alkon DL.

Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10167-71.

5.

Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.

Priller J, Briley EM, Mansouri J, Devane WA, Mackie K, Felder CC.

Mol Pharmacol. 1995 Aug;48(2):288-92.

PMID:
7651362
6.
7.

New dawn of cannabinoid pharmacology.

Devane WA.

Trends Pharmacol Sci. 1994 Feb;15(2):40-1. Review. No abstract available.

PMID:
8165721
8.

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J.

Pharmacol Biochem Behav. 1993 Dec;46(4):967-72.

PMID:
7906042
9.
10.

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.

Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA.

Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7656-60.

11.

Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R.

Science. 1992 Dec 18;258(5090):1946-9.

PMID:
1470919
12.

Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities.

Burstein SH, Audette CA, Breuer A, Devane WA, Colodner S, Doyle SA, Mechoulam R.

J Med Chem. 1992 Aug 21;35(17):3135-41.

PMID:
1507202
13.

A novel probe for the cannabinoid receptor.

Devane WA, Breuer A, Sheskin T, Järbe TU, Eisen MS, Mechoulam R.

J Med Chem. 1992 May 29;35(11):2065-9.

PMID:
1317925
14.

A random walk through a cannabis field.

Mechoulam R, Devane WA, Breuer A, Zahalka J.

Pharmacol Biochem Behav. 1991 Nov;40(3):461-4. Review.

PMID:
1806938
15.

Nonpsychotropic synthetic cannabinoids as therapeutic agents.

Mechoulam R, Breuer A, Feigenbaum JJ, Devane WA.

Farmaco. 1991 Jan;46(1 Suppl):267-76. Review. No abstract available.

PMID:
1854406
16.

The cannabinoid receptor: biochemical, anatomical and behavioral characterization.

Howlett AC, Bidaut-Russell M, Devane WA, Melvin LS, Johnson MR, Herkenham M.

Trends Neurosci. 1990 Oct;13(10):420-3. Review.

PMID:
1700516
17.

Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain.

Bidaut-Russell M, Devane WA, Howlett AC.

J Neurochem. 1990 Jul;55(1):21-6.

PMID:
2162376
18.

Determination and characterization of a cannabinoid receptor in rat brain.

Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC.

Mol Pharmacol. 1988 Nov;34(5):605-13.

PMID:
2848184
19.

An assessment of the role of opioid receptors in the response to cannabimimetic drugs.

Devane WA, Spain JW, Coscia CJ, Howlett AC.

J Neurochem. 1986 Jun;46(6):1929-35.

PMID:
3009717

Supplemental Content

Loading ...
Support Center